Review



vendor apc cy7 cd45 ox 1 bd pe cy7 cd11b c ox 42 bd fitc p2y12 n  (Alomone Labs)


Bioz Verified Symbol Alomone Labs is a verified supplier
Bioz Manufacturer Symbol Alomone Labs manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Alomone Labs vendor apc cy7 cd45 ox 1 bd pe cy7 cd11b c ox 42 bd fitc p2y12 n
    (A): Representative samples from both sham and CCI groups are shown. The single cell population was identified based on SSC and FSC. Live cells were identified as negative for the 7-AAD. Microglia were identified using a two-step method. First, <t>CD11b/c+</t> cells <t>(PE-Cy7)</t> were selected to identify all myeloid cells. The CD11b/c+ cells were then gated on <t>P2Y12</t> <t>(FITC)</t> and <t>CD45</t> <t>(APC-Cy7).</t> Microglia were identified as triple positive cells. SSC, side scatter; FSC, forward scatter. (B): The multiple color flow cytometry panel used to identify and immunophenotype microglia and peripheral myeloid cells.
    Vendor Apc Cy7 Cd45 Ox 1 Bd Pe Cy7 Cd11b C Ox 42 Bd Fitc P2y12 N, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 90/100, based on 10 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/vendor apc cy7 cd45 ox 1 bd pe cy7 cd11b c ox 42 bd fitc p2y12 n/product/Alomone Labs
    Average 90 stars, based on 10 article reviews
    vendor apc cy7 cd45 ox 1 bd pe cy7 cd11b c ox 42 bd fitc p2y12 n - by Bioz Stars, 2026-02
    90/100 stars

    Images

    1) Product Images from "Combination therapy with Treg and MSC enhances potency and attenuation of inflammation after traumatic brain injury compared to monotherapy"

    Article Title: Combination therapy with Treg and MSC enhances potency and attenuation of inflammation after traumatic brain injury compared to monotherapy

    Journal: Stem cells (Dayton, Ohio)

    doi: 10.1002/stem.3320

    (A): Representative samples from both sham and CCI groups are shown. The single cell population was identified based on SSC and FSC. Live cells were identified as negative for the 7-AAD. Microglia were identified using a two-step method. First, CD11b/c+ cells (PE-Cy7) were selected to identify all myeloid cells. The CD11b/c+ cells were then gated on P2Y12 (FITC) and CD45 (APC-Cy7). Microglia were identified as triple positive cells. SSC, side scatter; FSC, forward scatter. (B): The multiple color flow cytometry panel used to identify and immunophenotype microglia and peripheral myeloid cells.
    Figure Legend Snippet: (A): Representative samples from both sham and CCI groups are shown. The single cell population was identified based on SSC and FSC. Live cells were identified as negative for the 7-AAD. Microglia were identified using a two-step method. First, CD11b/c+ cells (PE-Cy7) were selected to identify all myeloid cells. The CD11b/c+ cells were then gated on P2Y12 (FITC) and CD45 (APC-Cy7). Microglia were identified as triple positive cells. SSC, side scatter; FSC, forward scatter. (B): The multiple color flow cytometry panel used to identify and immunophenotype microglia and peripheral myeloid cells.

    Techniques Used: Flow Cytometry

    Multicolor Flow Cytometry Microglia/Myeloid Cell Panel
    Figure Legend Snippet: Multicolor Flow Cytometry Microglia/Myeloid Cell Panel

    Techniques Used: Flow Cytometry



    Similar Products

    90
    Alomone Labs vendor apc cy7 cd45 ox 1 bd pe cy7 cd11b c ox 42 bd fitc p2y12 n
    (A): Representative samples from both sham and CCI groups are shown. The single cell population was identified based on SSC and FSC. Live cells were identified as negative for the 7-AAD. Microglia were identified using a two-step method. First, <t>CD11b/c+</t> cells <t>(PE-Cy7)</t> were selected to identify all myeloid cells. The CD11b/c+ cells were then gated on <t>P2Y12</t> <t>(FITC)</t> and <t>CD45</t> <t>(APC-Cy7).</t> Microglia were identified as triple positive cells. SSC, side scatter; FSC, forward scatter. (B): The multiple color flow cytometry panel used to identify and immunophenotype microglia and peripheral myeloid cells.
    Vendor Apc Cy7 Cd45 Ox 1 Bd Pe Cy7 Cd11b C Ox 42 Bd Fitc P2y12 N, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/vendor apc cy7 cd45 ox 1 bd pe cy7 cd11b c ox 42 bd fitc p2y12 n/product/Alomone Labs
    Average 90 stars, based on 1 article reviews
    vendor apc cy7 cd45 ox 1 bd pe cy7 cd11b c ox 42 bd fitc p2y12 n - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    Image Search Results


    (A): Representative samples from both sham and CCI groups are shown. The single cell population was identified based on SSC and FSC. Live cells were identified as negative for the 7-AAD. Microglia were identified using a two-step method. First, CD11b/c+ cells (PE-Cy7) were selected to identify all myeloid cells. The CD11b/c+ cells were then gated on P2Y12 (FITC) and CD45 (APC-Cy7). Microglia were identified as triple positive cells. SSC, side scatter; FSC, forward scatter. (B): The multiple color flow cytometry panel used to identify and immunophenotype microglia and peripheral myeloid cells.

    Journal: Stem cells (Dayton, Ohio)

    Article Title: Combination therapy with Treg and MSC enhances potency and attenuation of inflammation after traumatic brain injury compared to monotherapy

    doi: 10.1002/stem.3320

    Figure Lengend Snippet: (A): Representative samples from both sham and CCI groups are shown. The single cell population was identified based on SSC and FSC. Live cells were identified as negative for the 7-AAD. Microglia were identified using a two-step method. First, CD11b/c+ cells (PE-Cy7) were selected to identify all myeloid cells. The CD11b/c+ cells were then gated on P2Y12 (FITC) and CD45 (APC-Cy7). Microglia were identified as triple positive cells. SSC, side scatter; FSC, forward scatter. (B): The multiple color flow cytometry panel used to identify and immunophenotype microglia and peripheral myeloid cells.

    Article Snippet: SSC, side scatter; FSC, forward scatter. (B): The multiple color flow cytometry panel used to identify and immunophenotype microglia and peripheral myeloid cells. table ft1 table-wrap mode="anchored" t5 Table 1. caption a7 Fluorochrome Antibody Clone Vendor APC-Cy7 CD45 OX-1 BD PE-Cy7 CD11b/c OX-42 BD FITC P2Y12 n/a Alomone Labs PE CD32 D34–485 BD Alexa Fluor 647 RT1B OX-6 BD PerCP Cy5.5 7-AAD n/a BD Open in a separate window Multicolor Flow Cytometry Microglia/Myeloid Cell Panel Microglia gating strategy Conventional flow cytometry analyses were performed with FlowJo vr10.6.1.

    Techniques: Flow Cytometry

    Multicolor Flow Cytometry Microglia/Myeloid Cell Panel

    Journal: Stem cells (Dayton, Ohio)

    Article Title: Combination therapy with Treg and MSC enhances potency and attenuation of inflammation after traumatic brain injury compared to monotherapy

    doi: 10.1002/stem.3320

    Figure Lengend Snippet: Multicolor Flow Cytometry Microglia/Myeloid Cell Panel

    Article Snippet: SSC, side scatter; FSC, forward scatter. (B): The multiple color flow cytometry panel used to identify and immunophenotype microglia and peripheral myeloid cells. table ft1 table-wrap mode="anchored" t5 Table 1. caption a7 Fluorochrome Antibody Clone Vendor APC-Cy7 CD45 OX-1 BD PE-Cy7 CD11b/c OX-42 BD FITC P2Y12 n/a Alomone Labs PE CD32 D34–485 BD Alexa Fluor 647 RT1B OX-6 BD PerCP Cy5.5 7-AAD n/a BD Open in a separate window Multicolor Flow Cytometry Microglia/Myeloid Cell Panel Microglia gating strategy Conventional flow cytometry analyses were performed with FlowJo vr10.6.1.

    Techniques: Flow Cytometry